no more compounding glp 1 drugs Compounded GLP-1 medications are trending online, but not everything you hear is true. Your health deserves accurate information—not hype. Learn More: https://healthnothype.org/ #HealthNotHype #GLP1 #PatientSafety #HealthEducation #KnowTheFacts What Changed? The FDA's Clarification

Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies

The findings are a wake-up call that we cannot afford to ignore

Earlier this month (June 2025), Novo Nordisk reported that it will advance to Phase III trials both subcutaneous and oral amycretin in weight management based on completed clinical studies

A record 7.8% in spending growth in 2023 across Rhode Islands health system was partially driven by a surging amount of GLP-1 prescriptions, which doubled from 2022 to 2023

Lancet 2006;368:1696705.ArticlePubMed 22

In many cases, employer-sponsored health plans exclude weight-loss medications altogether, even when obesity-related conditions significantly impact overall health outcomes